CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | July/August 2016

MitraClip in the United States

Commercial use and COAPT trial updates.

By Mike Saji, MD, and D. Scott Lim, MD

cit | Article | September/October 2013

MitraClip for Functional MR

A review of MitraClip use and the COAPT trial in the heart failure population.

By Mike Saji, MD, and D. Scott Lim, MD

cit | Article | July/August 2010

Mitral Valve Repair Using the MitraClip System

What the EVEREST trials have told us about this first-generation percutaneous option for treating heart valve disease.

By D. Scott Lim, MD

cit | Article | July/August 2012

2012 PARTNER Trial Update

A review of the data that are currently available, as well as the issues that will be addressed in the next iteration of the PARTNER trial.

By D. Scott Lim, MD

Advertisement

Advertisement

cit | Article | July/August 2019

Update on Left Atrial Appendage Occlusion

An overview of innovative preprocedural and intraprocedural imaging techniques, trial data, and current LAAO devices and devices in development.

By Saurabh Sanon, MD, and D. Scott Lim, MD

cit | Article | September/October 2022

Transcatheter Edge-to-Edge Repair in Acute Decompensated Heart Failure

The feasibility of TEER for managing patients with severe mitral regurgitation in acute decompensated heart failure or cardiogenic shock.

By Ningyan Wong, MBBS; Nishtha Sodhi, MD; and D. Scott Lim, MD

cit | Article | July/August 2012

Aortic Valve Update

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

cit | Article | July/August 2016

Mitral Technology & Lesion Assessment

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | July/August 2019

Contemporary Catheter-Based Structural Heart and Vascular Access Closure Options

By Rahul Sharma, MD, FACP, FACC, FSCAI, and Nicolas M. Van Mieghem, MD, PhD, FACC, FESC

cit | News | September 17, 2022

Edwards' Pascal Precision System for TEER Studied at 6 Months in CLASP IID Trial

September 17, 2022—Edwards Lifesciences Corporation announced results from the prospective CLASP IID randomized controlled trial (RCT), which directly compared the safety and effectiveness of two contemporary transcatheter edge-to-edge repair (TEER) therapies: the Edwards Pascal Precision transcatheter valve repair system and the MitraClip system (Abbott).

cit | Article | September/October 2013

Valvular Interventions

By Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | Article | September/October 2022

Contemporary Mitral & Tricuspid Therapies

By Gagan D. Singh, MD, and Azeem Latib, MD

cit | Article | July/August 2010

Aortic and Mitral Valves

By Ted E. Feldman, MD, FSCAI

cit | News | March 20, 2013

FDA Advisory Committee Votes Favorably on Abbott Vascular's MitraClip

March 20, 2013—Abbott Vascular (Santa Clara, CA) announced that the US Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted by majority (yes: 5, no: 3) that the benefits of treatment with the company’s MitraClip device outweigh its risks in patients with significant symptomatic mitral regurgitation (MR) who have been determined by a cardiac surgeon to be too high risk for open mitral valve surgery and in whom existing comorbidities would not preclude the expected benefit from correction of the MR.

cit | News | March 17, 2025

Valcare Medical Receives IDE Approval for EFS of Amend Transseptal System

March 17, 2025—Valcare Medical Inc. recently announced that the FDA has approved the company’s investigational device exemption (IDE) application for the early feasibility study (EFS) of the Amend transseptal system for the treatment of mitral insufficiency.

cit | News | July 2, 2024

Valcare Medical Forms Scientific Advisory Board of Mitral Valve Experts

July 2, 2024—Valcare Medical, Inc., a developer of transcatheter-based mitral solutions based in Israel and Florida, announced the formation of a scientific advisory board composed of mitral valve experts.

cit | Article | January/February 2018

Interventional Therapies for Heart Failure

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Sponsored by Abiomed, Inc.

cit | Article | May/June 2020 Supplement

The Opportunity for Increased Quality Care and Shared Savings With the Impella® Heart Pump

By Charles Simonton, MD

cit | Article | September/October 2022

Contemporary Treatment of Tricuspid Regurgitation

Determining the appropriate candidates for surgical and transcatheter therapies and which devices to use.

By Marta Sitges, MD, PhD; Laura Sanchis, MD, PhD; Daniel Pereda, MD, PhD; and Xavier Freixa, MD, PhD


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button